Literature DB >> 22103778

Short stay and less pain after ambulatory anterior cruciate ligament (ACL) repair: COX-2 inhibitor versus glucocorticoid versus both combined.

V Dahl1, U J Spreng, M Waage, J C Raeder.   

Abstract

BACKGROUND: Many studies have demonstrated that either COX-2 antagonists or glucocorticoids are efficient analgesics after orthopaedic surgery. We wanted to evaluate if the combination of these two drugs was better than one drug alone when added to paracetamol, local anaesthesia, and cryo-cuff for outpatient anterior crucial ligament (ACL) surgery.
METHODS: In a double-blind design, 89 adult patients scheduled for day-case ACL repair in general anaesthesia were randomly assigned into three groups: The COXIB group (n = 30) received either 40 mg parecoxib iv or 120 mg etoricoxib orally 1 h before surgery. The STEROID group (n = 30) received 8 mg dexamethasone iv, and the combination group (Group COMBI, n = 29) received both.
RESULTS: At 24 h, Group COMBI had significantly lower visual analogue scale (0-10 cm) scores during rest (2.1 ± 1.3) (mean ± standard deviation) and movement (4.2 ± 2.5) when compared to both the COXIB group (P = 0.04) and the STEROID group (P = 0.035). The accumulated consumption of rescue opioids (5.2 ± 4,5 mg morphine) was also significantly lower at 24 h compared to the other groups (P = 0.02). Mean time to discharge from hospital was about 3 h in all groups. The pain scores in the post-anaesthetic care unit, mobilization at 24 h and 7 days, and general level of satisfaction were similar between the groups.
CONCLUSION: The combination of a COX-2 inhibitor and dexamethasone results in better pain relief 24 h after surgery in patients undergoing outpatient ACL surgery, compared to COX-2 inhibitor alone or dexamethasone alone. With a dedicated multimodal pain regime, most ACL patients may be discharged within 3 h.
© 2011 The Authors Acta Anaesthesiologica Scandinavica © 2011 The Acta Anaesthesiologica Scandinavica Foundation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22103778     DOI: 10.1111/j.1399-6576.2011.02584.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  6 in total

Review 1.  Pain after knee arthroplasty: an unresolved issue.

Authors:  Irina Grosu; Patricia Lavand'homme; Emmanuel Thienpont
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-11-08       Impact factor: 4.342

2.  Anterior cruciate ligament repair and peripheral nerve blocks: time to change our practice?

Authors:  R Ramlogan; S Tierney; C J L McCartney
Journal:  Br J Anaesth       Date:  2019-06-12       Impact factor: 9.166

3.  Analgesia after Epidural Dexamethasone is Further Enhanced by IV Dipyrone, but Not IV Parecoxibe Following Minor Orthopedic Surgery.

Authors:  Gabriela R Lauretti; Claudia Cf Righeti; Antonio T Kitayama
Journal:  Korean J Pain       Date:  2014-10-01

4.  Pain level after ACL reconstruction: A comparative study between free quadriceps tendon and hamstring tendons autografts.

Authors:  Cristian Tudor Buescu; Adela Hilda Onutu; Dan Osvald Lucaciu; Adrian Todor
Journal:  Acta Orthop Traumatol Turc       Date:  2017-02-27       Impact factor: 1.511

5.  Comparing the Efficacy of Postoperative Pain Control Between Intravenous Parecoxib and Oral Diclofenac in ACL Reconstruction.

Authors:  Chaiwat Chuaychoosakoon; Wachiraphan Parinyakhup; Arnan Wiwatboworn; Peeranut Purngpiputtrakul; Pawin Wanasitchaiwat; Tanarat Boonriong
Journal:  Orthop J Sports Med       Date:  2021-10-20

6.  Local controlled release of corticosteroids extends surgically induced joint instability by inhibiting tissue healing.

Authors:  Imke Rudnik-Jansen; Anna R Tellegen; Behdad Pouran; Karin Schrijver; Björn P Meij; Pieter J Emans; Erin de Gendt; Rachel E Thomas; Marja J L Kik; Huub M de Visser; Harrie Weinans; Annelies Egas; Erik van Maarseveen; Nina Woike; George Mihov; Jens Thies; Marianna A Tryfonidou; Laura B Creemers
Journal:  Br J Pharmacol       Date:  2019-10-08       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.